|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4704 | (2006.01) |
| A61K 31/4704 | (2013.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61K 39/395 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61K 38/179 | (2013.01) | ||
| C07K 16/00 | (2006.01) | ||
| C07K2319/30 | (2013.01) | ||
| C07K 16/22 | (2006.01) | ||
| C07K2319/32 | (2013.01) | ||
| C07K 16/22 | (2013.01) | ||
| C07K 16/00 | (2013.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/76 | (2013.01) |
| (11) | Patento numeris | 3886858 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20838435.4 |
| Europos patento paraiškos padavimo data | 2020-12-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-10-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-05-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2020/086993 |
| Data | 2020-12-18 |
| (87) | Numeris | WO 2021/123142 |
| Data | 2021-06-24 |
| (30) | Numeris | Data | Šalis |
| 19218062 | 2019-12-19 | EP | |
| 20156158 | 2020-02-07 | EP |
| (72) |
ERIKSSON, Helena , SE
KAYE, Joel , IL
TÖRNGREN, Marie , SE
|
| (73) |
Active Biotech AB ,
Box 724, 220 07 Lund,
SE
|
| (54) | COMPOUNDS FOR TREATMENT OF EYE DISEASES ASSOCIATED WITH EXCESSIVE VASCULARISATION |
| COMPOUNDS FOR TREATMENT OF EYE DISEASES ASSOCIATED WITH EXCESSIVE VASCULARISATION |